US$ 21.95
retatrutide 1mg (12mg Vial) Dosage Protocol Retatrutide Triple Agonist (GLP-1/GIP/GCG) |
Description
These trials test retatrutide for obesity, type 2 diabetes, cardiovascular disease, knee osteoarthritis, and liver disease (Giblin et al., Diabetes, Obesity and Metabolism 2026)

Additionally, by lowering blood sugar, improving cholesterol profiles, and potentially reducing inflammation, Retatrutide has shown potential to decrease the risk of cardiovascular events like heart attack or stroke

Dustin Olsen, a nutritionist and personal trainer who works with clients taking GLP-1 medications, says hes already seen people on compounded meds seek out cheaper and more dubiously sourced alternatives online, rather than switching to name brands

Your dentist will thank you for reading this paragraph

The idea was sparked by an episode of The Kardashians, where Scott was spotted with a GLP-1 pen in his fridge

Zepbound (Tirzepatide injection) Product Monograph
